{"References": [{"title": "Phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction", "authors": "Konstantinos Hatzimouratidis, Dimitrios G. Hatzichristou", "journal": "Current Pharmaceutical Design", "year": "2009", "volumes": "15", "first page": "3476", "last page": "3485", "DOI": "10.2174/138161209789206971"}, {"title": "Phosphodiesterase type 5 inhibitors: unmet needs", "authors": "Dimitrios Hatzimouratidis, Konstantinos Hatzichristou", "journal": "Current Pharmaceutical Design", "year": "2009", "volumes": "15", "first page": "3476", "last page": "3485", "DOI": "10.2174/138161209789206971"}, {"title": "Phosphodiesterase type 5 inhibitors: are they cardioprotective?", "authors": "Rakesh C. Kukreja, Fadi N. Salloum, Anindita Das, Ramzi Ockaili, Chen Yin, Yaser A. Bremer, Patrick W. Fisher, Michael Wittkamp, Jon Hawkins, Eric Chou, Amit K. Kukreja, Xia Wang, Vinh Q. Chau, Antonio Abbate", "journal": "Cardiovascular Research", "year": "2012", "volumes": "94", "first page": "206", "last page": "215", "DOI": "10.1093/cvr/cvr314"}, {"title": "Phosphodiesterase type 5 inhibitors and risk of melanoma: A meta-analysis", "authors": "Stacy Loeb, Eugenio Ventimiglia, Jeanette E. Salonia, Alfredo Folkvaljon, PÃ¤r Stattin", "journal": "Journal of the National Cancer Institute", "year": "2017", "volumes": "109", "first page": "djx086", "last page": "", "DOI": "10.1093/jnci/djx086"}, {"title": "Phosphodiesterase type 5 inhibitors and risk of skin cancer: A systematic review and meta-analysis", "authors": "Huilin Tang, Weilong Shi, Shuangshuang Fu, Tiansheng Wang, Suodi Zhai, Yiqing Song, Jiali Han", "journal": "Journal of the American Academy of Dermatology", "year": "2021", "volumes": "84", "first page": "1594", "last page": "1601", "DOI": "10.1016/j.jaad.2020.09.034"}, {"title": "Phosphodiesterase type 5 inhibitors and risk of Alzheimer's disease: A systematic review and meta-analysis", "authors": "Ruth Brauer, Liam Smeeth, Krishnan Anantharama, Wallis C.Y. Lau, Nish Chaturvedi, Ian C.K. Wong, Alastair J. Noyce, Li Wei", "journal": "Journal of Alzheimer's Disease", "year": "2021", "volumes": "79", "first page": "503", "last page": "514", "DOI": "10.3233/JAD-201031"}, {"title": "Phosphodiesterase type 5 inhibitors and risk of dementia: A systematic review and meta-analysis", "authors": "Yefeng Cai, Rui Wang, Mingyang Liang, Weijie Pan, Jie Chen, Jianfeng Li, Yinghao Sun", "journal": "Journal of Alzheimer's Disease", "year": "2021", "volumes": "80", "first page": "1039", "last page": "1050", "DOI": "10.3233/JAD-201174"}, {"title": "Phosphodiesterase type 5 inhibitors and risk of diabetes: A systematic review and meta-analysis", "authors": "Huilin Tang, Jiali Han, Shuangshuang Fu, Tiansheng Wang, Yiqing Song", "journal": "Journal of Diabetes Research", "year": "2020", "volumes": "2020", "first page": "4016327", "last page": "", "DOI": "10.1155/2020/4016327"}, {"title": "Phosphodiesterase type 5 inhibitors and risk of colorectal cancer: A systematic review and meta-analysis", "authors": "Huilin Tang, Weilong Shi, Shuangshuang Fu, Tiansheng Wang, Suodi Zhai, Yiqing Song, Jiali Han", "journal": "Cancer Medicine", "year": "2020", "volumes": "9", "first page": "3782", "last page": "3790", "DOI": "10.1002/cam4.3022"}, {"title": "Phosphodiesterase type 5 inhibitors and risk of prostate cancer: A systematic review and meta-analysis", "authors": "Huilin Tang, Jiali Han, Shuangshuang Fu, Tiansheng Wang, Yiqing Song", "journal": "Cancer Medicine", "year": "2020", "volumes": "9", "first page": "1362", "last page": "1370", "DOI": "10.1002/cam4.2784"}]}